"10.1371_journal.pone.0066223","plos one","2013-06-12T00:00:00Z","Philippe Morlat; Alexandre Vivot; Marie-Anne Vandenhende; Frédéric-Antoine Dauchy; Julien Asselineau; Edouard Déti; Yann Gerard; Estibaliz Lazaro; Pierre Duffau; Didier Neau; Fabrice Bonnet; Geneviève Chêne; the Groupe D’epidémiologie Clinique du Sida en Aquitaine (Gecsa)","Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique & CIC-EC7, Bordeaux, France; CHU de Bordeaux, Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), Bordeaux, France; CHU de Bordeaux, Pôle de Santé Publique, Coordination Régionale pour la Lutte contre le VlH (COREVIH), Bordeaux, France; CH de Dax, Service de Maladies Infectieuses, Dax, France; Univ. Bordeaux, UFR des sciences médicales, Bordeaux, France","Conceived and designed the experiments: PM GC. Performed the experiments: AV JA ED GC. Analyzed the data: PM AV JA ED. Contributed reagents/materials/analysis tools: AV JA. Wrote the paper: PM AV GC. Participated in patient’s recruitment: PM MAV FAD YG EL PD DN FB. Contributed to the paper discussion: MAV FAD YG EL ED PD DN FB.","In the past three years, PM has been on the board of Gilead sciences, Merck Sharp, Boehringer-Ingelheim, Dohme, Bristol Myers Squibb and ViiV healthcare. GC is an academic editor for PLOS ONE. FB has been on the board of Gilead sciences and ViiV healthcare. All others authors have no competing interests. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","Philippe Morlat","PM",13,FALSE,2,4,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
